Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice
Authors
Keywords
Rheumatoid Arthritis, Synovial Tissue, Mean Fluorescence Intensity, CCR9 Expression, Arthritis Score
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 16, Issue 5, Pages -
Publisher
Springer Nature
Online
2014-09-24
DOI
10.1186/s13075-014-0445-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis
- (2014) Aya Sato et al. Modern Rheumatology
- Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
- (2014) Norihiro Nishimoto et al. Modern Rheumatology
- Necessity of Lysophosphatidic Acid Receptor 1 for Development of Arthritis
- (2013) Yoshishige Miyabe et al. ARTHRITIS AND RHEUMATISM
- C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice
- (2013) Po-sung Chu et al. HEPATOLOGY
- A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease
- (2013) Satish Keshav et al. PLoS One
- Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial
- (2012) Paul P Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- A Systemically-Administered Small Molecule Antagonist of CCR9 Acts as a Tissue-Selective Inhibitor of Lymphocyte Trafficking
- (2012) Noah J. Tubo et al. PLoS One
- CCR9+ Macrophages Are Required for Acute Liver Inflammation in Mouse Models of Hepatitis
- (2011) Nobuhiro Nakamoto et al. GASTROENTEROLOGY
- Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety
- (2011) Y. KOMANO et al. JOURNAL OF RHEUMATOLOGY
- Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis
- (2011) Kayoko Kaneko et al. ARTHRITIS RESEARCH & THERAPY
- CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trial
- (2010) A. W. R. van Kuijk et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) D. Aletaha et al. ANNALS OF THE RHEUMATIC DISEASES
- Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation
- (2010) Caroline Schmutz et al. ARTHRITIS RESEARCH & THERAPY
- Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
- (2009) Beatrix Bartok et al. IMMUNOLOGICAL REVIEWS
- Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial
- (2008) Clarissa E. Vergunst et al. ARTHRITIS AND RHEUMATISM
- Protocol for the induction of arthritis in C57BL/6 mice
- (2008) Julia J Inglis et al. Nature Protocols
- Tumor necrosis factor inhibitors and infection complications
- (2008) Monica Crawford et al. Current Rheumatology Reports
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now